Loading…
← Back to schedule
Panel: Biotech Markets and IPOs: Trends from 2024 and Projections for 2025
Wednesday January 15, 2025 9:50am - 10:30am PST
Hyatt Regency San Francisco
The biotech market made a comeback in 2024, recovering from a slump a year earlier. What will the IPO window look like in 2025? During this panel discussion, we will examine the performance of companies that went public in the second half of 2024 and how their success or challenges are impacting other startups’ decisions on whether to go public themselves
Moderators
avatar for Gabrielle Masson

Gabrielle Masson

Associate Editor, Fierce Biotech
Gabrielle Masson is an associate editor for Fierce Biotech. Prior to Fierce, she worked at Becker's Hospital Review, where she reported on public health and the pandemic. Gabrielle graduated from the University of Wisconsin-Madison after studying creative writing and criminal justice... Read More →
Speakers
CD

Chirag D. Surti

Executive Director, Morgan Stanley
avatar for Maha Katabi

Maha Katabi

General Partner, Sofinnova Investments
avatar for Troy Ignelzi

Troy Ignelzi

CFO, Rapport Therapeutics
Troy has nearly two decades of financial leadership experience in the biotech and pharmaceuticals sectors. Over the course of his career, Troy has raised an impressive $4 billion-plus in capital for life science companies. Most recently, he was Chief Financial Officer at Karuna Therapeutics... Read More →
Wednesday January 15, 2025 9:50am - 10:30am PST
Hyatt Regency San Francisco
  Panel
  • Qtag Featured

Log in to save this to your schedule, view media, leave feedback and see who's attending!

Tweet Share
Share Modal

Share this link via

Or copy link